<DOC>
	<DOC>NCT00236236</DOC>
	<brief_summary>The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.</brief_summary>
	<brief_title>The HF-HRV Registry</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients receiving their first CRTD Patients who sign and date a Patient Informed Consent prior to device implant Patients who are available and willing to attend followup visits at the study center in which they were enrolled Patients who are anticipated to receive pacing modes other than DDD or VDD (i.e., chronic atrial fibrillation patients are excluded), or patients who are anticipated to receive adaptive rate therapy Patients who are younger than 18 years of age Patients whose life expectancy is less than sixmonths due to other medical conditions Patients with or who are likely to receive a tricuspid or other valve prosthesis Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study Women who are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
</DOC>